Disposition of Methamphetamine and Major Metabolites in Mice: Role of Organic Cation Transporter 3 in Tissue-Selective Accumulation of Para-Hydroxymethamphetamine
- 1 September 2018
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 46 (9) , 1277-1284
Abstract
Methamphetamine is one of the most widely abused illicit drugs. Although human intoxication and multiple tissue toxicities frequently occur in abusers, little is known about the distribution of methamphetamine or its primary metabolites, amphetamine and para-hydroxymethamphetamine (p-OHMA), to their sites of toxicity. This study determined the pharmacokinetics, tissue exposure, and partition ratios of methamphetamine and major metabolites in various mouse tissues and investigated the impact of organic cation transporter 3 (Oct3) following i.v. injection of methamphetamine to male Oct3+/+ and Oct3−/− mice. Methamphetamine, amphetamine, and p-OHMA were readily detectable in plasma with Oct3+/+ and Oct3−/− mice displaying similar plasma pharmacokinetic profiles for all three analytes. In addition to kidney and liver, salivary glands highly accumulated methamphetamine, amphetamine, and p-OHMA with total exposure 3.3- to 9.4-fold higher than plasma area under the concentration–time curve (AUC). Consistent with being an Oct3 substrate, p-OHMA AUC in salivary glands is reduced by 50% in Oct3−/− mice. p-OHMA AUC in skeletal muscle is also significantly reduced in Oct3−/− mice. Our data identified salivary glands as a novel site of high accumulation of methamphetamine and metabolites, which may underlie methamphetamine toxicity in this tissue. Furthermore, our study identified Oct3 as an important determinant of tissue uptake and exposure to p-OHMA in salivary glands and skeletal muscle. Our findings suggest that local tissue accumulation of methamphetamine and/or its metabolites may play a role in several of the reported peripheral toxicities of methamphetamine, and Oct3 can significantly impact tissue exposure to its substrates without affecting systemic elimination.Keywords
This publication has 34 references indexed in Scilit:
- Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical ImplicationsPLOS ONE, 2010
- Selective Transport of Monoamine Neurotransmitters by Human Plasma Membrane Monoamine Transporter and Organic Cation Transporter 3The Journal of Pharmacology and Experimental Therapeutics, 2010
- Estimation of pharmacokinetic parameters with the R package PKPharmaceutical Statistics, 2010
- Interaction of organic cation transporter 3 (SLC22A3) and amphetamineJournal of Neurochemistry, 2010
- Xenobiotic, Bile Acid, and Cholesterol Transporters: Function and RegulationPharmacological Reviews, 2010
- The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathwayProceedings of the National Academy of Sciences, 2009
- PET Studies of d-Methamphetamine Pharmacokinetics in Primates: Comparison with l-Methamphetamine and ( )-CocaineJournal of Nuclear Medicine, 2007
- Role of organic cation transporters in the renal handling of therapeutic agents and xenobioticsToxicology and Applied Pharmacology, 2005
- Clinical Pharmacokinetics of Amfetamine and Related SubstancesClinical Pharmacokinetics, 2004
- Resampling Methods in Sparse Sampling Situations in Preclinical Pharmacokinetic StudiesJournal of Pharmaceutical Sciences, 1998